Limitations, agreements, and source contact

Evaluation of Activity, Safety and Pharmacology of IPH2101 a Human Monoclonal Antibody in Patients With Multiple Myeloma · Source last updated 2016-03-24

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

false

restrictive Agreement

false

point Of Contact

email

attal.m@chu-toulouse.fr

organization

HOPITAL DE PURPAN Service Hematologie

phone

+33 (0)5.61.77.77.84

title

Dr Michel ATTAL

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice